Q1 2023 AddLife AB Earnings Call Transcript
()-&
Good morning, everyone, and welcome to the AddLife first quarter presentation. This morning, we will take you through the slide presentation and then open up for questions afterwards. And as always, if we don't have time for every question, don't hesitate to reach out to us for follow-up questions after the call.
I'm very happy to announce the fact that AddLife is starting the year in a very strong way. For a long time now, AddLife has been positioning the company for an expected recovery in the health care system after the pandemic. During the first quarter, we have seen this expected development happen in a significant way. Surgical procedures have been increasing all across Europe. And with that, we can see a strong organic growth of 13% in the Medtech business area and 10% in Labtech. On top of that, we see the margin development in a positive trend, supported by significant volumes, but also product mix and an efficient price management.
Looking at COVID-19, this may be the last
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |